jrnl665

Publication Venue For

  • Personality change during depression treatment: A placebo-controlled trial.  66:1322-1330. 2009
  • Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.  66:499-507. 2009
  • Selecting among second-step antidepressant medication monotherapies: Predictive value of clinical, demographic, or first-step treatment features.  65:870-881. 2008
  • Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-Sponsored WISE Study.  63:874-880. 2006
  • Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims.  63:639-648. 2006
  • Cognitive therapy vs medications in the treatment of moderate to severe depression.  62:409-416. 2005
  • Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.  62:417-422. 2005
  • Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: A postmortem brain study.  61:685-693. 2004
  • Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.  60:804-815. 2003
  • Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects.  60:273-282. 2003
  • Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression.  58:77-83. 2001
  • Decisional capacity for informed consent in schizophrenia research.  57:533-538. 2000
  • Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study.  57:1061-1069. 2000
  • Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex: Focal abnormalities in orbitofrontal cortex in schizophrenia.  54:1089-1095. 1997
  • Neocortical Abnormalities in Schizophrenia.  52:819-820. 1995